Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2.

Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS.

Blood. 1999 May 1;93(9):3044-52.

2.

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.

Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ.

Oncogene. 2002 Sep 19;21(42):6510-9.

3.

Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells.

Gazitt Y, Fey V, Thomas C, Alvarez R.

Int J Oncol. 1998 Aug;13(2):397-405.

PMID:
9664139
4.
6.
10.

Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.

Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC.

Oncogene. 2003 Jul 17;22(29):4498-508.

PMID:
12881706
11.
12.

Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation.

Jeon YJ, Han SH, Lee YW, Lee M, Yang KH, Kim HM.

Immunopharmacology. 2000 Jul 20;48(2):173-83.

PMID:
10936515
14.

Bcl-2 overexpression protects photooxidative stress-induced apoptosis of photoreceptor cells via NF-kappaB preservation.

Crawford MJ, Krishnamoorthy RR, Rudick VL, Collier RJ, Kapin M, Aggarwal BB, Al-Ubaidi MR, Agarwal N.

Biochem Biophys Res Commun. 2001 Mar;281(5):1304-12. Erratum in: Biochem Biophys Res Commun 2001 May 4;283(2):536.

PMID:
11243878
15.

Epothilones induce human colon cancer SW620 cell apoptosis via the tubulin polymerization independent activation of the nuclear factor-kappaB/IkappaB kinase signal pathway.

Lee SH, Son SM, Son DJ, Kim SM, Kim TJ, Song S, Moon DC, Lee HW, Ryu JC, Yoon DY, Hong JT.

Mol Cancer Ther. 2007 Oct;6(10):2786-97.

16.

Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.

Romagnoli M, Desplanques G, Maïga S, Legouill S, Dreano M, Bataille R, Barillé-Nion S.

Clin Cancer Res. 2007 Oct 15;13(20):6010-8.

17.

Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.

Song YS, Park HJ, Kim SY, Lee SH, Yoo HS, Lee HS, Lee MK, Oh KW, Kang SK, Lee SE, Hong JT.

Neurosci Res. 2004 May;49(1):69-80.

PMID:
15099705
18.

NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.

Heckman CA, Mehew JW, Boxer LM.

Oncogene. 2002 May 30;21(24):3898-908.

19.

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.

Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC.

Blood. 2002 Jun 1;99(11):4079-86.

20.

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis.

Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, Aggarwal BB.

Blood. 2004 Apr 15;103(8):3175-84. Epub 2003 Dec 18.

Supplemental Content

Support Center